BHV-4157: Clinical Trials

8 trials of BHV-4157, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 1 active not recruiting, 1 available. 3 Phase 2, 3 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Recruiting 1, Terminated 1
Phase 33Active not recruiting 1, Completed 1, Recruiting 1
Early Phase 11Recruiting 1

Follow BHV-4157: new trials by email Literature Review of BHV-4157 trials Research Report on BHV-4157

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
Troriluzole - Glioblastoma, Recurrent Glioblastoma
Early Phase 1RecruitingUgonma Chukwueke272025-02-192025-09-11
Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets
Ipilimumab, Nivolumab, Troriluzole - Melanoma, Metastatic Melanoma
Phase 2TerminatedDana-Farber Cancer Institute12021-06-302024-03-26
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Temozolomide, Lomustine, Regorafenib - Glioblastoma
Phase 2 / Phase 3RecruitingGlobal Coalition for Adaptive Research22502019-07-302026-11-02
Real-World Data Study of Troriluzole-Treated Patients With Spinocerebellar Ataxia (SCA) Compared to a Matched Natural History Control
BHV-4157 - Spinocerebellar Ataxias
CompletedBiohaven Therapeutics Ltd.9092019-03-182026-10-29
Randomized Trial of Adult Participants With Generalized Anxiety Disorder
Troriluzole, Placebo - Generalized Anxiety Disorder
Phase 3CompletedBiohaven Pharmaceuticals, Inc.8812019-02-192024-05-08
Study of BHV-4157 in Alzheimer's Disease
troriluzole, Placebo oral capsule - Alzheimer Disease
Phase 2CompletedBiohaven Pharmaceuticals, Inc.3502018-07-312023-12-06
Open Pilot Trial of BHV-4157
BHV-4157 - Spinocerebellar Ataxias, Spinocerebellar Ataxia Type 1
Phase 3Active not recruitingUniversity of California, Los Angeles242017-12-152024-05-09
Expanded Access Protocol of Troriluzole in Patients With Spinocerebellar Ataxia (SCA)
Troriluzole - SCA, Spinocerebellar Ataxias
AvailableBiohaven Pharmaceuticals, Inc.2026-01-09

Conditions studied

Spinocerebellar Ataxias (3)  ·  Glioblastoma (2)  ·  Alzheimer Disease (1)  ·  Brain Neoplasms (1)  ·  Generalized Anxiety Disorder (1)  ·  Machado-Joseph Disease (1)  ·  Melanoma (1)  ·  Recurrence (1)

Sponsors

Biohaven Pharmaceuticals, Inc. (3)  ·  Biohaven Therapeutics Ltd. (1)  ·  Dana-Farber Cancer Institute (1)  ·  Global Coalition for Adaptive Research (1)  ·  Ugonma Chukwueke (1)  ·  University of California, Los Angeles (1)

Countries

United States (7)  ·  Australia (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Switzerland (1)

Top investigators

Ann W Silk, MD, MS (1)  ·  Tim Cloughesy, MD (1)  ·  Ugonma Chukwueke, MD (1)

Results publications

PMID 38773224, PMID 39462179, PMID 40317057, PMID 41980234